US Patent 11312763 Anti-N3pGlu amyloid beta peptide antibodies and uses thereof
Patent 11312763 was granted and assigned to Eli Lilly and Company on April, 2022 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 11312763 Anti-N3pGlu amyloid beta peptide antibodies and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.